The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Second primary B-ALL after exposure to lenalidomide for multiple myeloma: A US multicenter study.
 
Arjun Lakshman
No Relationships to Disclose
 
Jeffrey Lee Jensen
Stock and Other Ownership Interests - Abbvie; Pfizer
 
Rajshekhar Chakraborty
No Relationships to Disclose
 
Gene Shaw
No Relationships to Disclose
 
Dragan Jevremovic
No Relationships to Disclose
 
Min Shi
No Relationships to Disclose
 
James R Cook
No Relationships to Disclose
 
Sara A Monaghan
No Relationships to Disclose
 
Jithma P. Abeykoon
No Relationships to Disclose
 
Ricardo Parrondo
No Relationships to Disclose
 
Peter Leif Bergsagel
Consulting or Advisory Role - CellCentric; Janssen; Mundipharma; Salarius Pharmaceuticals
Research Funding - Pfizer (I)
Patents, Royalties, Other Intellectual Property - Mouse model of multiple myeloma
Travel, Accommodations, Expenses - Celgene
 
Mounzer E. Agha
Stock and Other Ownership Interests - GenCart
 
Sam Rubinstein
Honoraria - Sanofi
Consulting or Advisory Role - Janssen; LAVA Therapeutics
 
Catherine Callaghan Coombs
Stock and Other Ownership Interests - Bluebird Bio; CTI BioPharma Corp
Honoraria - Abbvie; AstraZeneca; BeiGene; Genentech; H3 Biomedicine; Janssen; LOXO; MEI Pharma; MingSight; Novartis; Octapharm; Pharmacyclics; TG Therapeutics
Consulting or Advisory Role - Abbvie; Genentech; Lilly
Speakers' Bureau - Abbvie; AstraZeneca; BeiGene; Genentech
Research Funding - Loxo (Inst)
 
Sawa Ito
No Relationships to Disclose
 
Mithun Vinod Shah
No Relationships to Disclose
 
Anjali S. Advani
Consulting or Advisory Role - Amgen; Beam Therapeutics; Beam Therapeutics; Glycomimetics; Jazz Pharmaceuticals; Kite, a Gilead company; Kura Oncology; Nkarta; Novartis; Pfizer; Seagen; SERVIER; Taiho Oncology
Research Funding - Amgen (Inst); Beam Therapeutics (Inst); Glycomimetics (Inst); Immunogen (Inst); Incyte (Inst); Kite/Gilead (Inst); Macrogenics (Inst); OBI Pharma (Inst); Pfizer (Inst); Pfizer (Inst); Seagen (Inst); SERVIER (Inst)
 
Linda Baughn
Consulting or Advisory Role - Genentech
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); K36 (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); MedImmune (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Pfizer